Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page
- ChecktodayChange DetectedThe page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a software patch or update to the platform. This appears to be a routine version increment rather than a modification to the study content.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page's revision tag changed from v3.6.2 to v3.6.3, indicating a new build/version of the page.SummaryDifference0.0%

- Check29 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, indicating a site version update with no changes to the study details or page content.SummaryDifference0.0%

- Check43 days agoChange DetectedEnrollment status updated to 'No longer looking for participants' indicates the study is no longer enrolling. The update also adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizes the Intervention/Treatment label, and updates the UI version to v3.6.0.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, reflecting a minor update to the page version history. No substantive content changes are indicated.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page or its underlying system.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.